Intensity Therapeutics Treats First Patient with Combination of INT230-6 and Mer

This topic has 0 replies, 1 voice, and was last updated 4 years, 8 months ago by gavin.

Viewing 1 post (of 1 total)

Author

Posts
November 1, 2019 at 10:29 am #99253

gavin
Moderator

Intensity Therapeutics Treats First Patient with Combination of INT230-6 and Merck’s Keytruda®

https://www.businesswire.com/news/home/20191031005173/en/Intensity-Therapeutics-Treats-Patient-Combination-INT230-6-Merck%E2%80%99s
Author

Posts

Viewing 1 post (of 1 total)

The forum ‘New Developments’ is closed to new topics and replies.

©2022 - All Rights Reserved, Cholangiocarcinoma Foundation